Concepedia

Antony Loebel

AL

Statistics

Publications

117

Citations

7.7K

H-Index

47

Active since

1992

Affiliations

Vion Pharmaceuticals (United States)(Current)

Sunovion (United States)

Pfizer (United States)

New York Medical College

University of California San Diego

Antony Loebel is an author at Vion Pharmaceuticals (United States) specializing in medicine, psychiatry, and psychopathology.

ORCID

Top concepts

Publications per year

1992–2021

117

Publications

117

Duration of psychosis and outcome in first-episode schizophrenia

Antony Loebel, Jeffrey A. Lieberman, José Alvir et al. · American Journal of Psychiatry · 1992 · 879 citations

Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Antony Loebel, Josephine Cucchiaro, Robert Silva et al. · American Journal of Psychiatry · 2013 · 335 citations

Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study

Trisha Suppes, Robert Silva, Josephine Cucchiaro et al. · American Journal of Psychiatry · 2015 · 313 citations · Full text

Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study

Antony Loebel, Josephine Cucchiaro, Robert Silva et al. · American Journal of Psychiatry · 2013 · 287 citations

, , +15

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

Kenneth S. Koblan, Justine Kent, Seth C. Hopkins et al. · New England Journal of Medicine · 2020 · 278 citations

1–5 of 117